Overseas markets are central to MiniMed’s business, accounting for 70% of reported net sales in the company’s 2026 financial ...

MiniMed MMED recently announced the commercial launch of its MiniMed 780G automated insulin delivery system integrated with Abbott Laboratories' ABT Instinct sensor and the MiniMed Go system ...

MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced the commercial launch in Europe of both the ...

NORTHRIDGE, Calif., March 10, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a global leader in full stack insulin delivery, today announced CE (Conformité Européenne) Mark for use of the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Ali Dianaty, MiniMed’s chief product and technology officer, believes the company is “clearly ahead” of the competition in ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Medtronic begins broad U.S. rollout of MiniMed 780G with Abbott's Instinct sensor for type 1 diabetes. Pairing MiniMed 780G with Abbott's Instinct sensor strengthens Medtronic's diabetes management ...

Medtronic plcMDT announced that the FDA has approved a new arm indication for the Guardian Sensor 3 continuous glucose monitor (CGM) used with the MiniMed 670G insulin pump. Notably, the Guardian ...

NORTHRIDGE, Calif., June 3, 2026 /PRNewswire/ -- MiniMed (NASDAQ: MMED), a global leader in diabetes technology, today announced an expanded agreement with Abbott to collaborate on commercializing ...

The MarketWatch News Department was not involved in the creation of this content. NORTHRIDGE, Calif., March 10, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a global leader in full stack ...